The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 23, 2024
Filed:
May. 26, 2022
Petra Pharma Corporation, New York, NY (US);
Erin Danielle Anderson, Arvada, CO (US);
Sean Douglas Aronow, Boulder, CO (US);
Nicholas A. Boyles, Hillsboro, OR (US);
Xiaohong Chen, Broomfield, CO (US);
Surendra Dawadi, Longmont, CO (US);
Eugene R. Hickey, Danbury, CT (US);
Thomas Combs Irvin, Erie, CO (US);
Edward A. Kesicki, New York, NY (US);
Gabrielle R. Kolakowski, Durango, CO (US);
Jennifer Lynn Knight, Jersey City, NJ (US);
Manoj Kumar, Broomfield, CO (US);
Katelyn Frances Long, Lafayette, CO (US);
Christopher Glenn Mayne, Boulder, CO (US);
Johnathan Alexander McLean, Boulder, CO (US);
Gerit Maria Pototschnig, San Diego, CA (US);
Hua-Yu Wang, Chula Vista, CA (US);
Michael Brian Welch, Westminster, CO (US);
Tien Widjaja, Lafayette, CO (US);
PETRA PHARMA CORPORATION, New York, NY (US);
Abstract
The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I): or pharmaceutically acceptable salts thereof wherein R, R, R, R, R, R, R, R, and R, are as defined herein. The disclosure also relates to methods of making and using compounds of Formula (I) or pharmaceutically acceptable salts thereof.